UMB Bank’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
UMB Bank's HAE Position: Q2 2026 in Review
UMB Bank reduced its Haemonetics (HAE) stake by 37% in Q2 2026, selling an estimated $15.3K and leaving 400 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.
UMB Bank first reported a position in HAE in Q4 2021 and has held it in 19 quarters since. The position peaked at $49.9K in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- UMB Bank held 400 shares of Haemonetics worth $30K as of Q2 2026.
- UMB Bank sold 238 Haemonetics shares in Q2 2026, an estimated $15.3K.
- Haemonetics made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1522 holding.
- UMB Bank first reported a position in Haemonetics in Q4 2021 and has held it in 19 quarters since.
- UMB Bank's Haemonetics position peaked at $49.9K in Q2 2025.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.